Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment
Authors:
- Juliana Rocha SantosJSJuliana Rocha Santos
- Paulo Roberto Xavier TomazPTPaulo Roberto Xavier Tomaz
- Jaqueline Ribeiro ScholzJaqueline Ribeiro Scholz
- Patrícia Viviane GayaPGPatrícia Viviane Gaya
- Tânia Ogawa AbeTATânia Ogawa Abe
- José Eduardo KriegerJKJosé Eduardo Krieger
- Alexandre Costa PereiraAPAlexandre Costa Pereira
- Paulo Caleb Júnior de Lima SantosPSPaulo Caleb Júnior de Lima Santos
Open Access
Abstract
Introduction: Smoking is considered the leading cause of preventable morbidity and mortality worldwide. Studies have sought to identify predictors of response to smoking cessation treatments. The aim of this study was to analyze a possible association of target gene expression for smoking cessation with varenicline. Methods: We included 74 smokers starting treatment with varenicline. Gene expression analysis was performed through the custom RT² Profiler qPCR array assay, including 17 genes. Times for sample collection were before the start of therapy (T0) and two weeks (T2) and four weeks (T4) after the start of treatment. Results: For gene expression analysis, we selected 14 patients who had success and 13 patients resistant to varenicline treatment. Success was considered to be when a patient achieved tobacco abstinence until the fourth week of treatment and resistant was when a patient had not stopped smoking as of the fourth week of treatment. We observed a significant difference for CHRNA7 gene expression: in the resistant group, samples from T2 and T4 had lower expression compared with T0 (fold change: 0.38, P = 0.007; fold change: 0.67, P = 0.004; respectively). Conclusion: This exploratory clinical study, searching for a possible predictor of effectiveness for varenicline, reaffirmed the association of the α7 nAChR subunit for nicotine dependence and smoking therapy effectiveness with varenicline.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/09295-3)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (470410/2013-2)
This publication has 56 references indexed in Scilit:
- Neuroadaptive Changes Associated with Smoking: Structural and Functional Neural Changes in Nicotine DependenceBrain Sciences, 2013
- Nicotinic Mechanisms in the Treatment of Psychotic Disorders: A Focus on the α7 Nicotinic Receptor2012
- Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical TrialsNeuropsychopharmacology, 2011
- Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genesThe Pharmacogenomics Journal, 2011
- Associations of Nicotine Intake Measures With CHRN Genes in Finnish SmokersNicotine & Tobacco Research, 2011
- Neurocircuitry of AddictionNeuropsychopharmacology, 2009
- Differential Regulation of α7 Nicotinic Receptor Gene (CHRNA7) Expression in Schizophrenic SmokersJournal of Molecular Neuroscience, 2009
- Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genesAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2009
- Differentiating nicotine- versus schizophrenia-associated decreases of the α7 nicotinic acetylcholine receptor transcript, CHRFAM7A, in peripheral blood lymphocytesJournal of Neural Transmission, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001